Mode
Text Size
Log in / Sign up
N/A Completed N=87 Randomized Double-blind Treatment

Performance Comparison Between Comfilcon A and Senofilcon C Lenses

Source: ClinicalTrials.gov NCT02920957 ↗
Enrolled (actual)
87
Serious AEs
0.6%
Results posted
Jan 2018
Primary outcomePrimary: Overall Lens Fit Acceptance — 3.6; 3.5; 3.5; 3.5 units on a scale

Summary

The aim of this study is to determine the clinical performance of comfilcon A in comparison to senofilcon C.

Outcome Measures

OutcomeResultp-value
PRIMARY
Overall Lens Fit Acceptance
3.6; 3.5; 3.5; 3.5; 3.5; 3.3 —
PRIMARY
Corneal Coverage
85; 84; 82; 83; 82; 83 —
PRIMARY
Lens Centration
77; 78; 76; 71; 71; 76 —
PRIMARY
Post-blink Movement
1.8; 1.9; 1.9; 1.9; 1.9; 1.8 —
PRIMARY
Lens Lag at Primary Gaze
0.2; 0.2; 0.2; 0.2; 0.2; 0.2 —
PRIMARY
Tightness on Push up
54; 51; 51; 54; 53; 53 —
PRIMARY
Lens Wettability
3.8; 3.5; 3.4; 3.7; 3.3; 3.3 —
PRIMARY
Deposit Grading
0.0; 0.3; 0.5; 0.1; 0.4; 0.7 —

Eligibility Criteria

Inclusion Criteria

A person is eligible for inclusion in the study if he/she:

  • Is between 18 and 34 years of age (inclusive)
  • Has had a self-reported eye exam in the last two years
  • Is a spherical soft contact lens wearer
  • Has a contact lens spherical prescription between -1.00 to -6.00 (inclusive)
  • Has a spectacle cylinder no greater than 0.75D (Diopters) in each eye.
  • Can achieve best corrected spectacle distance visual acuity of 20/25 (0.10 logMAR) or better in each eye.
  • Can achieve a distance visual acuity of 20/30 (0.18 logMAR) or better in each eye with the study contact lenses.
  • Has clear corneas and no active ocular disease
  • Has read, understood and signed the information consent letter.
  • Has a contact lens prescription that fits within the available parameters of the study lenses.
  • Is willing and anticipated to be able to comply with the wear schedule (at least 6 days per week, 12 hours/day assuming there are no contraindications for doing so).
  • Is willing to comply with the visit schedule

Exclusion Criteria

A person will be excluded from the study if he/she:

  • Has a history of not achieving comfortable CL (contact lens) wear (defined as 6 days per week; > 10 hours/day)
  • Presents with clinically significant anterior segment abnormalities
  • Presents with ocular or systemic disease or need of medications which might interfere with contact lens wear.
  • Presents with slit lamp findings that would contraindicate contact lens wear such as:
  • Pathological dry eye or associated findings
  • Significant pterygium, pinguecula, or corneal scars within the visual axis
  • Neovascularization > 0.75 mm in from of the limbus
  • Giant papillary conjunctivitis (GCP) worse than grade 1
  • Anterior uveitis or iritis (or history in past year)
  • Seborrheic eczema of eyelid region, Seborrheic conjunctivitis
  • History of corneal ulcers or fungal infections
  • Poor personal hygiene
  • Has a known history of corneal hypoesthesia (reduced corneal sensitivity)
  • Has aphakia, keratoconus or a highly irregular cornea.
  • Has presbyopia or has dependence on spectacles for near work over the contact lenses.
  • Has undergone corneal refractive surgery.
  • Is participating in any other type of eye related clinical or research study.
  • Is habitually using rewetting/ lubricating eye drops more than once per day
  • Is currently wearing daily disposable lenses
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT02920957). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.

Back to search